Allianz Asset Management GmbH - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 224 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$718,146
-20.5%
14,3000.0%0.00%
-50.0%
Q2 2023$903,760
-51.1%
14,300
-60.9%
0.00%0.0%
Q2 2022$1,848,000
-53.5%
36,591
-41.1%
0.00%
-33.3%
Q1 2022$3,970,000
-56.6%
62,148
-27.1%
0.00%
-50.0%
Q4 2021$9,151,000
-5.5%
85,246
-9.5%
0.01%
-25.0%
Q3 2021$9,688,000
+85.8%
94,234
+59.0%
0.01%
+100.0%
Q2 2021$5,213,000
-4.4%
59,264
+5.6%
0.00%
-20.0%
Q1 2021$5,455,000
-11.7%
56,105
+1.8%
0.01%
-16.7%
Q4 2020$6,180,000
+797.0%
55,102
+523.8%
0.01%
+500.0%
Q2 2020$689,000
+7.2%
8,833
-19.7%
0.00%0.0%
Q1 2020$643,000
-76.9%
11,004
-68.4%
0.00%
-66.7%
Q4 2019$2,788,000
-8.0%
34,808
-15.6%
0.00%0.0%
Q3 2019$3,029,000
-22.5%
41,264
-0.4%
0.00%
-25.0%
Q2 2019$3,907,000
+31.2%
41,418
+11.3%
0.00%
+33.3%
Q1 2019$2,979,000
+70.4%
37,203
+12.6%
0.00%
+50.0%
Q4 2018$1,748,000
-42.2%
33,029
-14.8%
0.00%
-33.3%
Q3 2018$3,026,000
+11.6%
38,773
-9.2%
0.00%0.0%
Q2 2018$2,712,000
-23.5%
42,721
+10.5%
0.00%0.0%
Q1 2018$3,546,000
+8.5%
38,668
-10.8%
0.00%0.0%
Q4 2017$3,269,000
+549.9%
43,343
+499.8%
0.00%
Q3 2017$503,000
-66.3%
7,226
-80.6%
0.00%
-100.0%
Q1 2017$1,493,000
+41.8%
37,336
-0.5%
0.00%0.0%
Q4 2016$1,053,000
-16.4%
37,533
-11.5%
0.00%0.0%
Q3 2016$1,260,00042,4300.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders